Lantheus Holdings (LNTH) Change in Accured Expenses (2014 - 2026)
Lantheus Holdings (LNTH) reported Change in Accured Expenses of $23.0 million for Q1 2026, up 591.23% year-over-year from $3.3 million in Q1 2025, and up 15.89% quarter-over-quarter from $19.8 million in Q4 2025.
Lantheus Holdings (LNTH) Change in Accured Expenses (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Change in Accured Expenses data on file, last reported at $23.0 million in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at $23.0 million, up 591.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.6 million (up 3092.66% YoY), and the FY2025 annual result was -$9.1 million, down 119.42% from the prior year.
- Change in Accured Expenses grew to $23.0 million in Q1 2026 per LNTH's latest filing, from $19.8 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $50.4 million in Q1 2024 and troughed at -$123.8 million in Q2 2023.
- A 5-year average of $2.5 million and a median of $8.1 million in 2023 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses surged 1237.99% in 2023, then tumbled 1553.76% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at $33.2 million in 2022, then sank by 75.66% to $8.1 million in 2023, then soared by 249.39% to $28.2 million in 2024, then declined by 29.7% to $19.8 million in 2025, then gained by 15.89% to $23.0 million in 2026.
- Business Quant data shows LNTH's Change in Accured Expenses at $23.0 million in Q1 2026, $19.8 million in Q4 2025, and -$26.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 23.00 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 10.02 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 14.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.00 Mn |
| Mar 31, 2026 | 23.00 Mn |
| Dec 31, 2025 | 19.85 Mn |
| Dec 31, 2025 | 19.85 Mn |
| Sep 30, 2025 | -26.31 Mn |
| Sep 30, 2025 | -26.31 Mn |
| Jun 30, 2025 | -5.95 Mn |
| Jun 30, 2025 | -5.95 Mn |
| Mar 31, 2025 | 3.33 Mn |
| Mar 31, 2025 | 3.33 Mn |
| Dec 31, 2024 | 28.24 Mn |
| Dec 31, 2024 | 28.24 Mn |
| Sep 30, 2024 | 1.81 Mn |
| Sep 30, 2024 | 1.81 Mn |
| Jun 30, 2024 | -33.73 Mn |
| Jun 30, 2024 | -33.73 Mn |
| Mar 31, 2024 | 50.45 Mn |
| Mar 31, 2024 | 50.45 Mn |
| Dec 31, 2023 | 8.08 Mn |
| Dec 31, 2023 | 8.08 Mn |